Device
Cardiac Resynchronization Therapy Defibrillator
Cardiac Resynchronization Therapy Defibrillator is a medical device with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Cardiac Resynchronization in the Elderly
NCT03031847
completednot_applicable
Junctional AV Ablation in CRT-D: JAVA-CRT
NCT02946853
completedphase_4
Quartet Lead and Resynchronization Therapy Options
NCT01295840
terminated
Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients
NCT00758121
Clinical Trials (4)
Showing 4 of 4 trials
NCT03031847Not Applicable
Cardiac Resynchronization in the Elderly
NCT02946853Not Applicable
Junctional AV Ablation in CRT-D: JAVA-CRT
NCT01295840Phase 4
Quartet Lead and Resynchronization Therapy Options
NCT00758121
Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4